Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaquesEBIOMEDICINEIF10.82022-12-0110OAAI
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challengesEXPERT OPINION ON DRUG DELIVERYIF5.42022-10-2528OAAI
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer雷洛昔芬透皮递送的制剂开发,雷洛昔芬是一种针对乳腺癌的化学预防剂PHARMACEUTICSIF5.52022-03-2017OAAI
Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless ratsINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22020-05-017OAAI
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBVPHARMACEUTICSIF5.52019-04-0949OAAI
Clinical experience and follow-up with large-scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testingAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYIF8.42015-08-012PREAI
Prevention of carbon tetrachloride-induced hepatotoxicity by the ethanol extract of Capparis moonii fruits in ratsPHARMACEUTICAL BIOLOGYIF4.82008-09-2914PREAI